STOCK TITAN

Global Cord Blood appoints Michael Snape to board

The report also recounts the Grand Court of the Cayman Islands' September 22, 2022 order appointing three joint provisional liquidators.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

Global Cord Blood Corp (CORBF) appointed Michael Snape to its board on September 15, 2026, replacing Michael Weiss, who resigned on May 14, 2026. Xu Ping, also a board member, passed away on November 12, 2025. The company also recounts that on September 22, 2022, the Grand Court of the Cayman Islands appointed Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited, and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited, as joint provisional liquidators.

Board appointment September 15, 2026 Michael Snape appointed to the board, replacing Michael Weiss
Board resignation May 14, 2026 Michael Weiss resigned from the board
Board member's death November 12, 2025 Board member Xu Ping passed away
Court order appointing joint provisional liquidators September 22, 2022 Grand Court of the Cayman Islands order
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
joint provisional liquidators regulatory
"as joint provisional liquidators of Global Cord Blood Corporation"
Joint provisional liquidators are temporary, court-appointed officials who take control of a troubled company's assets and affairs while a formal winding-up or insolvency process is being decided. Think of them as emergency guardians who stop value being lost, secure records, and assess whether creditors or shareholders can recover funds. Investors pay attention because their appointment usually signals serious financial distress, potential suspension of trading, and uncertainty about how much, if anything, will be repaid.
Form 20-F regulatory
"annual reports under cover of Form 20-F"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who joined the Global Cord Blood Corp (CORBF) board?

Michael Snape joined the board on September 15, 2026, replacing Michael Weiss, who resigned on May 14, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
 
FORM 6-K 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of October 2026
 
Commission File Number: 001-34541
 
GLOBAL CORD BLOOD CORPORATION
(Translation of registrant’s name into English)
 
48th Floor, Bank of China Tower
1 Garden Road
Central
Hong Kong S.A.R.
(Address of Principal Executive Offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F ⌧  Form 40-F ☐
 
 
 



Introductory Note
On September 22, 2022, the Grand Court of the Cayman Islands issued an order appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited, and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited, as joint provisional liquidators of Global Cord Blood Corporation (the “Company”) pursuant to Section 104(2) of the Companies Act (as amended) of the Cayman Islands.
Changes to Global Cord Blood Corporation’s Board of Directors

On November 12, 2025, Xu Ping, a member of the Board of Directors (the “Board”), passed away. On May 14, 2026, Michael Weiss resigned as a member of the Board. On September 15, 2026, the Company appointed Michael Snape as a member of the Board, replacing Mr. Weiss.


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
GLOBAL CORD BLOOD CORPORATION
 
 
 
 
By:
   /s/ John Royle
 
Name: 
John Royle
 
Title:
Joint Provisional Liquidator by Order of the Grand Court of the Cayman Islands
 
Dated: October 22, 2026
 
 

 

Keep reading